Summary & Overview
CPT 26260: Radical Resection of Proximal or Middle Phalanx Tumor
CPT code 26260 represents a radical surgical resection of a fast-growing benign or malignant tumor of the proximal or middle phalanx, performed when lesions are recurrent, aggressive, or metastatic. This procedure is clinically significant because it addresses tumors that threaten function and may require wide excision to achieve local control, with implications for surgical planning, post‑operative rehabilitation, and resource use in operative settings.
Key payers considered in national coverage and reimbursement discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise synthesis of the clinical context for CPT code 26260, typical sites of service, common payer considerations, and what to expect in claims processing. The publication outlines benchmarks and policy-relevant updates where available, as well as coding relationships and typical service-line placement.
This summary equips clinicians, billing professionals, and policymakers with the essential information to identify when CPT code 26260 applies, understand its clinical importance, and locate the sections detailing payer practices, procedural benchmarks, and related coding guidance.
Billing Code Overview
CPT code 26260 describes a radical resection of a tumor of the proximal or middle phalanx. The procedure involves removal of a fast-growing benign or malignant tumor along with surrounding healthy tissue and is used for recurrent, aggressive, or metastatic tumors.
Service type: Surgical oncology / hand surgery — tumor resection with radical margins
Typical site of service: Operating room or ambulatory surgical center; hand and upper extremity surgical setting
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient presents with a rapidly enlarging, painful mass of the proximal phalanx of the index finger. Imaging (hand radiographs and MRI) demonstrates a destructive lesion suspicious for an aggressive benign tumor (e.g., recurrent giant cell tumor of tendon sheath) or primary malignant bone tumor with cortical breach. The patient has progressive functional limitation and concern for local invasion. After multidisciplinary review, the hand surgeon schedules a radical resection of the proximal phalanx under regional or general anesthesia with planned excision of the tumor and a margin of uninvolved soft tissue and bone. Intraoperative steps include tourniquet application, longitudinal or dorsal incision, careful dissection to preserve neurovascular bundles when feasible, en bloc resection of the involved phalanx segment, assessment for clear margins, possible skeletal stabilization or local flap coverage, and specimen submission for permanent pathology. Postoperative workflow includes pain control, wound checks, pathology review to confirm margin status, and hand therapy for range of motion and functional recovery. Follow-up may include oncologic consultation if malignant or metastatic disease is confirmed and adjuvant therapy is considered.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Provider is primary surgeon | When the reporting surgeon is the primary operator performing the radical resection |